Isolated Bone Lytic Lesions as a Form of Presentation of Gastric Cancer with Signet Ring Cells

Anoceto Martínez A¹, Ruiz Hernández JJ^{1, 2,} , Mohamad Tubio M³ and González Pinedo L⁴

¹Internal Medicine Department, Hospital Universitario de Gran Canaria “Dr Negrín”, Las Palmas, Spain

²University of Las Palmas de Gran Canaria, Spain

³Department of Radiology, Hospital Universitario de Gran Canaria “Dr Negrín”, Las Palmas, Spain

⁴Department of Hematology, Hospital Universitario de Gran Canaria “Dr Negrín”, Las Palmas, Spain

Cite this paper

Anoceto Martínez A, Ruiz Hernández JJ, Mohamad Tubio M and González Pinedo L. Isolated Bone Lytic Lesions as a Form of Presentation of Gastric Cancer with Signet Ring Cells. American Journal of Medical Case Reports. 2020; 8(7):182-184. doi: 10.12691/AJMCR-8-7-5

Abstract

Gastric cancer (GC) is still the second most common cause of cancer-related death worldwide. In addition, gastric cancer is the most commonly diagnosed malignancy in Korea, Japan, China, South America and Eastern European nations, with the lowest frequency observed in the United States and Canada. Metastatic gastric cancer is a therapeutic challenge for medical oncologists, especially those with bone marrow metastases. Bone marrow metastases occur in many solid tumors such as breast, lung, prostate and gastric cancer [1]. Our case is about a woman diagnosed of gastric adenocarcinoma with signet ring cells presenting with bone marrow infiltration.

Keywords

gastric cancer, signet ring cell, bone marrow metastasis; lytic bone metastasis

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Kim HS, Yi SY, Jun HJ, Lee J, Park JO, Park YS, et al. Clinical outcome of gastric cancer patients with bone marrow metastases. Oncology. 2007; 73: 192-7.
[2]	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424.
[3]	Shah MA, Khanin R, Tang L, Janjigian YY, Klimstra DS, Gerdes H et al. Molecular classification of gastric cancer: a new paradigm. Clin Cancer Res 2011; 17: 2693-701.
[4]	Bamboat ZM, Tang LH, Vinuela E, et al. Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma. Ann Surg Oncol 2014; 21: 1678-85.
[5]	Polom K, Marrelli D, D’Ignazio A, Roviello F. Hereditary diffuse gastric cancer: how to look for and how to manage it. Updates Surg. 2018 Jun; 70(2): 161-166.
[6]	Ekinci AŞ, Bal O, Ozatl T, Türker I, Eşbah O, Demirci A et al. Gastric carcinoma with bone marrow metastasis: a case series. J Gastric Cancer 2014; 14(1): 54-57.
[7]	Iovino F, Orditura M, Auriemma PP, Ciorra FR, Giordano G, Orabona C et al. Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. Oncol Lett. 2015 Mar; 9(3): 1403-1405.
[8]	Dittus C, Mathew H, Malek A, Negroiu A. Bone marrow infiltration as the initial presentation of gastric signet ring cell adenocarcinoma.J Gastrointest Oncol 2014; 5(6): E113-E116.
[9]	Kim YJ, Kim SH, Kim JW, Lee JO, Kim JH, Bang SM et al. Gastric cancer with initial bone metastasis: a distinct group of diseases with poor prognosis. Eur J Cancer. 2014 Nov; 50(16): 2810-21.